Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants

Hepatology. 1997 Aug;26(2):251-5. doi: 10.1002/hep.510260237.
No abstract available

Publication types

  • Review

MeSH terms

  • Genetic Therapy*
  • Hepatitis, Viral, Human / therapy*
  • Humans
  • Mutation
  • Oligonucleotides, Antisense / therapeutic use*
  • RNA, Catalytic / therapeutic use*
  • Viral Interference

Substances

  • Oligonucleotides, Antisense
  • RNA, Catalytic